Global Anti-Mullerian Hormone Test Market Size Study, by Product, by End-User, by Distribution, by Use, and Regional Forecasts 2022-2032

Description

Global Anti-Mullerian Hormone (AMH) Test Market is valued at approximately USD 274.26 million in 2023 and is anticipated to grow with a healthy growth rate of more than 11.46% over the forecast period 2024-2032. AMH tests are crucial diagnostic tools in reproductive medicine, providing essential information about ovarian reserve, egg quantity, and potential fertility. These tests are particularly valuable in assessing conditions such as polycystic ovary syndrome (PCOS) and primary ovarian insufficiency (POI) and are instrumental in in vitro fertilization (IVF) procedures for medication dosing and predicting ovarian response. The growing awareness of reproductive health issues, the necessity for early and precise fertility diagnosis, and the increasing age of first-time pregnancies drive the demand for AMH tests. Technological advancements and expanding healthcare infrastructure further enhance accessibility and affordability. However, the limited awareness in low-resource settings and the high cost of tests, coupled with the need for standardized testing protocols, present challenges to market penetration. Moreover, technological integration for interpreting AMH levels and related fertility factors offers significant growth opportunities.

Point-of-care (POC) testing is increasingly preferred for its immediate results, enabling swift decision-making in clinical practice. These tests are designed for ease of use and rapid results, ideal for healthcare providers needing to streamline fertility evaluations. Self-check kits cater to individuals seeking privacy and convenience, providing an initial step in fertility investigation from home. Commercial labs serve clinicians and specialists with advanced diagnostic tools, ensuring efficiency and reliability for high-volume testing. Research and development (R&D) institutions demand high-sensitivity tests for advancing fertility and reproductive health research. The distribution channels are evolving, with a growing preference for online platforms that offer detailed product information and user reviews, catering to consumers seeking convenience and privacy.

In humans, AMH tests assess ovarian reserve and fertility potential, crucial for fertility treatments and reproductive health evaluations. In non-human primates, these tests assist in conservation efforts and breeding program management, providing insights into reproductive potential.

The key regions considered for the global Anti-Mullerian Hormone (AMH) Test Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia-Pacific is a dominating region in the Anti-Mullerian Hormone (AMH) Test Market in terms of revenue. The market growth in the region is being attributed to factors including increasing healthcare expenditures and awareness. Also, the region lead with advanced healthcare infrastructure and significant R&D investments. Whereas, the market in Europe is anticipated to grow at the fastest rate over the forecast period fueled by enhancing healthcare infrastructures and policies.

Major market players included in this report are:

Abbexa Limited
Abcam PLC
Ansh Labs LLC
Athenese-Dx
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
bioMerieux S.A.
BioVendor - Laboratorni Medicina A.S.
Chengdu VACURE Biotechnology Co., Ltd.
CTK Biotech, Inc.
Cusabio Technology LLC
Eagle Biosciences, Inc.
Elabscience Bionovation Inc.
Epitope Diagnostics, Inc.
F. Hoffmann-La Roche Ltd.

The detailed segments and sub-segment of the market are explained below:

By Product:

POC Testing
Self-check Kits

By End-User:

Commercial Labs
Research & Development

By Distribution:

Offline Channels
Online Channels

By Use:

Human
Non-Human Primate

By Region:

North America:

U.S.
Canada

Europe:

UK
Germany
France
Spain
Italy
ROE

Asia Pacific:

China
India
Japan
Australia
South Korea
RoAPAC

Latin America:

Brazil
Mexico

Middle East & Africa:

Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Anti-Mullerian Hormone (AMH) Test Market Executive Summary

1.1. Global Anti-Mullerian Hormone (AMH) Test Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Product
- 1.3.2. By End-User
- 1.3.3. By Distribution
- 1.3.4. By Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Anti-Mullerian Hormone (AMH) Test Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Anti-Mullerian Hormone (AMH) Test Market Dynamics

3.1. Market Drivers
- 3.1.1. Rising awareness and incidence of reproductive health issues
- 3.1.2. Increasing age of first-time pregnancies necessitating fertility assessments
- 3.1.3. Advancements in diagnostic technologies
3.2. Market Challenges
- 3.2.1. Limited awareness in low-resource settings
- 3.2.2. High cost and need for standardized testing protocols
3.3. Market Opportunities
- 3.3.1. Technological integration for interpreting AMH levels
- 3.3.2. Expansion of healthcare infrastructure globally

Chapter 4. Global Anti-Mullerian Hormone (AMH) Test Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Anti-Mullerian Hormone (AMH) Test Market Size & Forecasts by Product 2022-2032

5.1. Segment Dashboard
5.2. Global Anti-Mullerian Hormone (AMH) Test Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 5.2.1. POC Testing
- 5.2.2. Self-check Kits

Chapter 6. Global Anti-Mullerian Hormone (AMH) Test Market Size & Forecasts by End-User 2022-2032

6.1. Segment Dashboard
6.2. Global Anti-Mullerian Hormone (AMH) Test Market: End-User Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 6.2.1. Commercial Labs
- 6.2.2. Research & Development

Chapter 7. Global Anti-Mullerian Hormone (AMH) Test Market Size & Forecasts by Distribution 2022-2032

7.1. Segment Dashboard
7.2. Global Anti-Mullerian Hormone (AMH) Test Market: Distribution Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 7.2.1. Offline Channels
- 7.2.2. Online Channels

Chapter 8. Global Anti-Mullerian Hormone (AMH) Test Market Size & Forecasts by Use 2022-2032

8.1. Segment Dashboard
8.2. Global Anti-Mullerian Hormone (AMH) Test Market: Use Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 8.2.1. Human
- 8.2.2. Non-Human Primate

Chapter 9. Global Anti-Mullerian Hormone (AMH) Test Market Size & Forecasts by Region 2022-2032

9.1. North America Anti-Mullerian Hormone (AMH) Test Market
- 9.1.1. U.S. Anti-Mullerian Hormone (AMH) Test Market
  - 9.1.1.1. Product breakdown size & forecasts, 2022-2032
  - 9.1.1.2. End-User breakdown size & forecasts, 2022-2032
  - 9.1.1.3. Distribution breakdown size & forecasts, 2022-2032
  - 9.1.1.4. Use breakdown size & forecasts, 2022-2032
- 9.1.2. Canada Anti-Mullerian Hormone (AMH) Test Market
9.2. Europe Anti-Mullerian Hormone (AMH) Test Market
- 9.2.1. U.K. Anti-Mullerian Hormone (AMH) Test Market
- 9.2.2. Germany Anti-Mullerian Hormone (AMH) Test Market
- 9.2.3. France Anti-Mullerian Hormone (AMH) Test Market
- 9.2.4. Spain Anti-Mullerian Hormone (AMH) Test Market
- 9.2.5. Italy Anti-Mullerian Hormone (AMH) Test Market
- 9.2.6. Rest of Europe Anti-Mullerian Hormone (AMH) Test Market
9.3. Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market
- 9.3.1. China Anti-Mullerian Hormone (AMH) Test Market
- 9.3.2. India Anti-Mullerian Hormone (AMH) Test Market
- 9.3.3. Japan Anti-Mullerian Hormone (AMH) Test Market
- 9.3.4. Australia Anti-Mullerian Hormone (AMH) Test Market
- 9.3.5. South Korea Anti-Mullerian Hormone (AMH) Test Market
- 9.3.6. Rest of Asia Pacific Anti-Mullerian Hormone (AMH) Test Market
9.4. Latin America Anti-Mullerian Hormone (AMH) Test Market
- 9.4.1. Brazil Anti-Mullerian Hormone (AMH) Test Market
- 9.4.2. Mexico Anti-Mullerian Hormone (AMH) Test Market
- 9.4.3. Rest of Latin America Anti-Mullerian Hormone (AMH) Test Market
9.5. Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market
- 9.5.1. Saudi Arabia Anti-Mullerian Hormone (AMH) Test Market
- 9.5.2. South Africa Anti-Mullerian Hormone (AMH) Test Market
- 9.5.3. Rest of Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market

Chapter 10. Competitive Intelligence

10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
- 10.3.1. Abbexa Limited
- 10.3.2. Abcam PLC
- 10.3.3. Ansh Labs LLC
- 10.3.4. Athenese-Dx
- 10.3.5. Bio-Rad Laboratories, Inc.
- 10.3.6. Bio-Techne Corporation
- 10.3.7. bioMerieux S.A.
- 10.3.8. BioVendor - Laboratorni Medicina A.S.
- 10.3.9. Chengdu VACURE Biotechnology Co., Ltd.
- 10.3.10. CTK Biotech, Inc.
- 10.3.11. Cusabio Technology LLC
- 10.3.12. Eagle Biosciences, Inc.
- 10.3.13. Elabscience Bionovation Inc.
- 10.3.14. Epitope Diagnostics, Inc.
- 10.3.15. F. Hoffmann-La Roche Ltd.

Chapter 11. Research Process

11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
11.2. Research Attributes